|
MTPAP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.41702230347119E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08389971945167E-10 |
| Normal-vs-Stage2 |
3.578500E-04 |
| Normal-vs-Stage3 |
4.80340212050123E-11 |
| Normal-vs-Stage4 |
8.79885053706175E-12 |
| Stage1-vs-Stage2 |
1.804980E-01 |
| Stage1-vs-Stage3 |
4.859800E-02 |
| Stage1-vs-Stage4 |
2.861600E-03 |
| Stage2-vs-Stage3 |
1.471700E-02 |
| Stage2-vs-Stage4 |
7.765400E-04 |
| Stage3-vs-Stage4 |
1.923000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.01247956871975E-13 |
| Normal-vs-AfricanAmerican |
6.758500E-04 |
| Normal-vs-Asian |
1.52000000364083E-08 |
| Caucasian-vs-AfricanAmerican |
5.269800E-01 |
| Caucasian-vs-Asian |
9.117200E-01 |
| AfricanAmerican-vs-Asian |
6.606800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.90639981368213E-10 |
| Normal-vs-Female |
1.75810477287541E-11 |
| Male-vs-Female |
6.550800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.40019995598095E-09 |
| Normal-vs-Age(41-60Yrs) |
5.24229548659605E-11 |
| Normal-vs-Age(61-80Yrs) |
9.01700003552719E-09 |
| Normal-vs-Age(81-100Yrs) |
6.156700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.135400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.949600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.073400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.034400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.753000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.270000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.907820E-02 |
| Classical-VS-Follicular |
6.141700E-02 |
| Classical-VS-Other |
5.094300E-02 |
| Classical-VS-Normal |
3.43179928918858E-11 |
| Tall-VS-Follicular |
5.967000E-04 |
| Tall-VS-Other |
9.036000E-01 |
| Tall-VS-Normal |
2.81120016154546E-10 |
| Follicular-VS-Other |
6.904600E-03 |
| Follicular-VS-Normal |
1.002230E-04 |
| Other-VS-Normal |
9.27700000041831E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.58919996554141E-09 |
| Normal-vs-N1 |
1.13900000542344E-09 |
| N0-vs-N1 |
4.840200E-02 |
|
|
